LFA Statement on the Administration's Decision Not to Move Forward with Proposed Rebate Reforms in Medicare Part D
The Lupus Foundation of America is extremely disappointed that the Administration has decided not to move forward with its proposed rule that would have lowered out-of-pocket costs and allowed patients to directly benefit from manufacturer-negotiated discounts and rebates.
People living with lupus take an average of eight medications. They and millions of others living with serious and chronic conditions could have had their drug costs reduced as the proposed rule would have fixed the broken rebate system. Instead, middlemen and insurance companies will continue to benefit from rebates, and those who rely on medicines the most will not.
We remain committed to working with the Administration and Congress to lower out-of-pocket costs for people with lupus and others living with chronic conditions and ensure they have access to the care they need.